companiesandmarkets.com

Return to Report | Print

XenoPort Inc - Premium Company Profile

http://www.companiesandmarkets.com/Summary-Company-Profile/xenoport-inc-premium-company-profile-41247.asp

Report Summary

Introduction

XenoPort is a biopharmaceutical company with therapeutic focus in the areas of central nervous system (CNS) and gastrointestinal tract (GI). Its product pipeline is based on its proprietary Transported Prodrug technology platform, which is focused on improving upon the pharmacologic properties of currently available therapeutics.

Scope

  • Contains corporate strategy, value chain presence and SWOT Analysis
  • Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
  • Includes information on suppliers/ partners, shareholding structure and key employees with biographies


    • Highlights

    XenoPort's pipeline includes XP19986, indicated for gastro-esophageal reflux disease (Phase IIa) and spasticity (Phase I), and XP13512 indicated for Restless Legs Syndrome (Phase III) and neuropathic pain (Phase IIa).

    The key elements ofit's business strategy include: entering into strategic alliances with other pharmaceutical/biotechnology companies for discovery, development and commercialization of its product candidates; advancing clinical development of its product candidates; and Transported Prodrug to discover new product candidates.

    The company's total revenues increased at a CAGR of 99.2% during 2002-2006, from $0.7 million to $10.6 million. The company's only contributor to revenue growth during 2002-2006 was revenues from license, collaboration and others.

    Reasons to Purchase

  • Access all the important information and analysis on the company in a single report
  • Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
  • Gain access to company's adjusted five year financial data along with key ratios and market capitalization

    • Table of Contents

    TABLE OF CONTENTS
    Overview 1
    Catalyst 1
    Summary 1
    Company Structure 6
    Company Overview and Key Facts 6
    Business Description 7
    History 9
    Company Financials 10
    Stock Market Performance 10
    P&L 11
    Balance Sheet 14
    Cash Flow 14
    Business Segment Performance 15
    Products & Services 16
    Pipeline Products 16
    AC Forecast Product Sales 18
    Competitors and Strategic Business Relationships 20
    Key Competitors 20
    Key Clients 21
    Shareholding Structure 22
    Strategy 23
    Company View 23
    Corporate Strategy 25
    SWOT Analysis 26
    Overview 26
    Strengths 27
    Weaknesses 29
    Opportunities 30
    Threats 31
    Value Chain Analysis 32
    Overview 32
    Product Development 33
    Scorecard 34
    Overview 34
    Scorecard Analysis 35
    Key Employees 36
    List of Key Employees 36
    Key Employee Biographies 37
    Financial and Operational Overview 44
    Financial and Operational Overview 44
    APPENDIX 47
    Ask the analyst 47
    Datamonitor consulting 47
    Disclaimer 47


    TABLE OF FIGURES
    Figure 1: XenoPort - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 12
    Figure 2: XenoPort - Key Strategic Revenues, 2006-2010 ($ Mn) 19


    TABLE OF TABLES
    Table 1: XenoPort - Key Facts 6
    Table 2: XenoPort - Year-End Share Price and Market Capitalization, 2002-2006 ($) 10
    Table 3: XenoPort - Key Events Impacting Share Price Performance 10
    Table 4: XenoPort - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 11
    Table 5: XenoPort - Operating Cost Ratio Analysis, 2002-2006 (% of total revenues) 13
    Table 6: XenoPort - Balance Sheet, 2002-2006 ($ Mn) 14
    Table 7: XenoPort – Cash Flow, 2002-2006 ($ Mn) 14
    Table 8: XenoPort - Revenue Breakdown by Division, 2002-2006 ($ Mn) 15
    Table 9: XenoPort - In-house Pipeline Products 16
    Table 10: XenoPort - Collaboration Products 17
    Table 11: XenoPort - Forecast Sales, 2006-2010 ($ Mn) 18
    Table 12: XenoPort - Key Competitors 20
    Table 13: XenoPort - Key Clients 21
    Table 14: XenoPort - Key Shareholders 22
    Table 15: XenoPort - SWOT Analysis Summary 26
    Table 16: XenoPort - Value Chain Analysis 32
    Table 17: XenoPort - Scorecard 34
    Table 18: XenoPort - Key Employees 36
    Table 19: XenoPort - Financial and Operational Overview 45